DE60322562D1 - Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik - Google Patents

Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik

Info

Publication number
DE60322562D1
DE60322562D1 DE60322562T DE60322562T DE60322562D1 DE 60322562 D1 DE60322562 D1 DE 60322562D1 DE 60322562 T DE60322562 T DE 60322562T DE 60322562 T DE60322562 T DE 60322562T DE 60322562 D1 DE60322562 D1 DE 60322562D1
Authority
DE
Germany
Prior art keywords
technetium
aza
diaminedioxime
conjugates
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322562T
Other languages
German (de)
English (en)
Inventor
Georg Brauers
Gillian Farrar
David Jonathan Barnett
Harry John Wadsworth
Joanne Sarah Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Application granted granted Critical
Publication of DE60322562D1 publication Critical patent/DE60322562D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60322562T 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik Expired - Lifetime DE60322562D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0224799.7A GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions
PCT/GB2003/004573 WO2004037297A1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic

Publications (1)

Publication Number Publication Date
DE60322562D1 true DE60322562D1 (de) 2008-09-11

Family

ID=9946533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322562T Expired - Lifetime DE60322562D1 (de) 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik

Country Status (16)

Country Link
EP (1) EP1553986B1 (enExample)
JP (1) JP2006508084A (enExample)
KR (1) KR20050070080A (enExample)
CN (1) CN1708322A (enExample)
AT (1) ATE402720T1 (enExample)
AU (1) AU2003279444A1 (enExample)
BR (1) BR0315578A (enExample)
CA (1) CA2501684A1 (enExample)
DE (1) DE60322562D1 (enExample)
ES (1) ES2309361T3 (enExample)
GB (1) GB0224799D0 (enExample)
MX (1) MXPA05004418A (enExample)
NO (1) NO20051811L (enExample)
RU (1) RU2005110960A (enExample)
WO (1) WO2004037297A1 (enExample)
ZA (1) ZA200502835B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
GB0520527D0 (en) * 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
GB0614337D0 (en) * 2006-07-19 2006-08-30 Acal Energy Ltd Fuel Cells
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
ES2804509T3 (es) 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
ES2739504T3 (es) 2010-12-21 2020-01-31 Ge Healthcare Ltd Uso de anilina en la radioestabilización de una ligadura de oxima
JP5934246B2 (ja) * 2010-12-22 2016-06-15 テーエフシム グリコ−cf2−セリンおよびグリコ−cf2−トレオニンの誘導体
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
US20130195756A1 (en) * 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
CN112830940B (zh) * 2020-09-07 2022-03-01 中国科学院宁波材料技术与工程研究所 2,5-呋喃二甲醛肟金属络合物及其制备方法、及在抗菌除霉消毒剂中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69937996T2 (de) * 1998-05-15 2009-01-02 Ge Healthcare Ltd., Little Chalfont Markierte glutamin- und lysinanaloge
WO2001077145A2 (en) * 2000-04-12 2001-10-18 Amersham Health As Integrin binding peptide derivatives
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates

Also Published As

Publication number Publication date
BR0315578A (pt) 2005-10-25
KR20050070080A (ko) 2005-07-05
WO2004037297A1 (en) 2004-05-06
NO20051811D0 (no) 2005-04-14
ES2309361T3 (es) 2008-12-16
CN1708322A (zh) 2005-12-14
MXPA05004418A (es) 2005-11-23
EP1553986A1 (en) 2005-07-20
RU2005110960A (ru) 2005-11-20
ZA200502835B (en) 2006-03-29
GB0224799D0 (en) 2002-12-04
ATE402720T1 (de) 2008-08-15
EP1553986B1 (en) 2008-07-30
CA2501684A1 (en) 2004-05-06
JP2006508084A (ja) 2006-03-09
AU2003279444A1 (en) 2004-05-13
NO20051811L (no) 2005-06-27

Similar Documents

Publication Publication Date Title
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
ATE487498T1 (de) Verbesserte radiometall-komplex-zusammensetzungen
Ramogida et al. H2 CHX dedpa and H4 CHX octapa Chiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals
DE60322562D1 (de) Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
CA2958475C (en) Mono-, di- or oligosaccharide used as metal inhibitors in the preparation of radioactive metal-chelate-functionalized target agents
UA32577C2 (uk) Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів
IL175667A (en) Imaging factor that includes a synthetic caspase-3 inhibitor marked with the neuroimaging agent, a radiopharmaceutical containing it, a kit for preparation of the preparation and a method for diagnosis based on it
WO2007042781A3 (en) Automated method for preparing technetium complexes
NO20070348L (no) Improved N4 Chelator Conjugates
ATE556722T1 (de) Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs
Rattat et al. Comparison of tridentate ligands in competition experiments for their ability to form a [99mTc (CO) 3] complex
TR199802091T2 (xx) Alfa-17 ikame/ katk�lama maddesi i�ermeyen yeni pregnan t�revleri.
DE69723242D1 (de) Ternäre radiopharmazeutische komplexe
Pandurangi et al. Chemistry of bifunctional photoprobes. 1. perfluoroaryl azido functionalized phosphorus hydrazides as novel photoreactive heterobifunctional chelating agents: high efficiency nitrene insertion on model solvents and proteins
WO2007076339A3 (en) Isotopically labelled crosslinking agents for the analysis of protein interactions
Banerjee et al. Site directed maleimide bifunctional chelators for the M (CO) 3+ core (M= 99m Tc, Re)
Su et al. A Novel Amine− Dioxime Chelator for Technetium-99m: Synthesis and Evaluation of 2-Nitroimidazole-Containing Analogues as Markers for Hypoxic Cells
Biechlin et al. Improvement in radiolabelling proteins with the 99mTc‐tricarbonyl‐core [99mTc (CO) 3]+, by thiol‐derivatization with iminothiolane: application to γ‐globulins and annexin V
Xu et al. Synthesis and evaluation of hydroxamamide-based tetradentate ligands as a new class of thiol-free chelating molecules for 99mTc radiopharmaceuticals
GB0421987D0 (en) Novel technetium and rhenium complexes
NO20055334L (no) Bifunksjonelle tridentate pyrazolylinneholdende ligander for RE og TC trikarbonylkomplekser
WO2003027148A8 (en) Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging
ATE521591T1 (de) 11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittel
Ferdani et al. Synthesis, Cu (II) complexation, 64Cu-labeling and biological evaluation of CB-TE1A1P
Holland et al. 89Zr-chemistry in the design of novel radiotracers for immunoPET

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1553986

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB